CAM
CADX

ClariVest Asset Management’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

ClariVest Asset Management’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,057
Closed -$119K – 728
2013
Q4 		$119K Buy
+13,057
New +$94.3K 0.01% 410

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClariVest Asset Management's CADX Position: Q1 2014 in Review

ClariVest Asset Management sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 13,057 shares — an estimated $119K sold.

ClariVest Asset Management first reported a position in CADX in Q4 2013 and held it in 1 quarter. The position peaked at $119K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • ClariVest Asset Management reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • ClariVest Asset Management sold 13,057 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $119K.
  • ClariVest Asset Management first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q4 2013 and held it in 1 quarter.
  • ClariVest Asset Management's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $119K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on ClariVest Asset Management's 13F filing for Q1 2014, filed 6 May 2014.